When the Cincinnati Bengals waived Matt Lee early this week, it was yet another proverbial nail in the coffin of the team’s ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ('HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several ...

The NFL Draft is less of a betting event for casual bettors, but markets do exist on a lot of picks — and BetMGM has odds on ...

Galapagos And Gilead Enter Into Binding Agreement To Collaborate On Advancing First In Class T Cell Engager Program For Autoimmune Diseases. New collaboration structure achieves meaningfully improved ...

Dylan became the public face of an aggressive new phase in Trump’s mass deportation campaign. His school never stopped trying ...

The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution ...

Russia put into operation its first near-surface final nuclear waste repository for solid low- and intermediate-level ...

Soroptimist International of Ramona: 6 to 6:30 p.m. social time, 6:30 p.m. meeting, Hatfield Creek Vineyards and Winery, 1625 ...

Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T cell- ...

Ideaya Biosciences begins patient dosing in phase 1 trial of IDE574, a potential first-in class dual inhibitor of KAT6/7 to target multiple solid tumour indications, including bre ...

When the stomach is full, how does the brain know to stop eating? Scientists long assumed the answer lies mainly with neurons ...

PARG is a next-generation DDR target with significant potential in PARP inhibitor-resistant cancers Preclinical data show ...